Keyword Tag Sort by

Categories: Apicomplexa FR235222 Malaria Parasites Toxoplasmosis

A first step towards an original drug candidate against toxoplasmosis and malaria?

The team coordinated by Mohamed-Ali Hakimi, working within the “Adaptation et pathogénie des micro-organismes” (Adaptation and pathogenesis of micro-organisms) Laboratory (CNRSUniversité Joseph Fourier Mixed Unit, Grenoble), in conjunction with researchers from Grenoble, Marseille and Paris, has just shown that a molecule – known as FR235222 – is capable of specifically repressing the activity of an enzyme produced by parasites of animal cells, such as those responsible for malaria and toxoplasmosis. It thus transpires that this molecule, which blocks the intracellular proliferation of the parasite, is a possible candidate in the quest for a new drug against these infections. The results of these works are published today in The Journal of Experimental medicine.

The life cycle of the Apicomplexa parasites, a family of animal cell parasites to which the Toxoplasma and Plasmodium parasites belong, alternates between intense proliferation and differentiation. It implicates a sophisticated control of the genes. However, the molecular mechanisms of this control remain obscure. Mohamed-Ali Hakimi, Inserm research leader, and his colleagues have put forward the hypothesis of a major contribution on the part of the structure of the chromosomes to the control of gene expression in Apicomplexa. For the purposes of validating this hypothesis, they tested the effect of several molecules capable of impairing structural modifications of histones (proteins which are linked to the DNA in order to form the chromatin (1) ).

FR235222 is a ring-form peptide produced by a filamentous fungus. It was shown that FR23522 inhibits enzymes called histone deacetylases, themselves capable of increasing the level of condensation of certain regions of the chromatin and consequently of repressing the expression of certain genes. Thus, FR23522 would seem to allow certain genes that regulate the development of the parasite to express themselves by lifting the repression mediated by the histone deacetylases. The work carried out by Mr Hakimi’s team showed that the FR235222 peptide influences the expression of about 5% of the parasitic genes (369 out of an estimated total of 7817). The addition of this molecule in a culture of parasites induces the differentiation of the tachyzoites – replicative (proliferative) form – into bradyzoites – non-replicative form, FR235222 is thus capable of limiting or even inhibiting the proliferation of the parasite.

Lastly, the authors showed that the action of the FR235222 molecule on the parasites is facilitated by the unique presence of an amino acid inserted in the catalytic site of a histone deacetylase, exclusively in the Apicomplexa. “This enzyme is thus a serious candidate for the development of a drug against toxoplasmosis and malaria”, in the opinion of the researchers.

This work in the field of epigenetics (a discipline studying the factors modifying the expression of the genes) should in the medium term lead to the development of molecules equivalent to FR235222, forecast the authors. For Mr Hakimi and his colleagues, work in this field will also involve an improved study, in the animal (mouse), of the capacity of FR235222 to eliminate the parasites (Toxoplasma and Plasmodium).

Mr Hakimi benefits from an Inserm Interface Contract with Professor Pelloux of the University Hospital of Grenoble

(1) Form in which the genetic material is presented in the cell nuclei

For further information

“Drug-inhibition of HDAC3 and epigenetic control of differentiation in Apicomplexa parasites”
Alexandre Bougdour,1 Danièle Maubon,1,2 Patricia Baldacci,6 Philippe Ortet,3 Olivier Bastien,4 Anthony Bouillon,5 Jean-Christophe Barale,5 Hervé Pelloux,1,2 Robert Menard,6 Mohamed-Ali Hakimi,1*
1 UMR5163, Laboratoire Adaptation et Pathogénie des Micro-organismes, CNRS-Université Joseph Fourier
Grenoble 1, BP 170, F-38042 Grenoble cedex 9, France.
2Parasitologie–Mycologie, Département des Agents Infectieux, Centre Hospitalier Universitaire, BP 217, 38043
Grenoble, cedex 09, France.
3 CEA, DSV, IBEB, LEMiRE, CNRS, Université Aix-Marseille II, CEA Cadarache, F-13108 Saint-Paul-lez-
Durance, France
4 UMR 5168 CNRS-CEA-INRA-Université J. Fourier, Laboratoire de Physiologie Cellulaire Végétale;
Département Réponse et Dynamique Cellulaire; CEA Grenoble, 17 rue des Martyrs, F-38054, Grenoble cedex
09, France.
5 Unité d'Immunologie Moléculaire des Parasites, Département de Parasitologie et de Mycologie, URA CNRS
2581, Institut Pasteur, Paris, 75724, France.
6 Unité de Biologie et Génétique du Paludisme, Institut Pasteur, Paris, France.

The Journal of experimental Medicine


Research contact:
Mohamed-Ali Hakimi, Tel : 04 76 63 74 69, Mel :
Inserm press contact, Séverine Ciancia, Tel : 01 44 23 60 86, Mel :

Source: Inserm, Institut national de la santé et de la recherche médicale


Related News:

Malaria's Severity Reset by Mosquito 31 May 2013, 05:42
The way malaria is transmitted controls how strongly the host's immune system reacts.For the...

Fingerprinting malaria parasite drug resistance 29 April 2013, 03:35
New genome sequencing technologies provide insight into emerging artemisinin resistance and a...

RTS,S malaria candidate vaccine reduces malaria by approximately... 9 November 2012, 03:56
-Results from ongoing Phase III clinical trial announced-Friday 9 November 2012, London UK--...

Diet Could Combat Adverse Side-Effects of Quinine 11 September 2012, 04:35
Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic...

Genetically Engineered Bacteria Prevent Mosquitoes from... 16 July 2012, 16:59
Researchers at the Johns Hopkins Malaria Research Institute have genetically modified a...

New Malaria Maps to Guide Battle Against the Disease 24 January 2012, 05:20
A new suite of malaria maps has revealed the current global pattern of the disease in...

Anti-malaria drug synthesised with the help of oxygen and light 17 January 2012, 06:35
In future it should be possible to produce the best anti-malaria drug, artemisinin, more...

New candidate malaria vaccine neutralises parasite strains 21 December 2011, 02:55
A new candidate malaria vaccine with the potential to neutralise all strains of the most deadly...

Malaria during pregnancy: new study assesses risks during first... 14 December 2011, 08:03
The largest ever study to assess the effects of malaria and its treatment in the first...

Malaria deaths are down but progress remains fragile 13 December 2011, 09:41
13 December 2011 | Geneva - Malaria mortality rates have fallen by more than 25% globally...